BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25065594)

  • 1. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.
    Park JT; Johnson N; Liu S; Levesque M; Wang YJ; Ho H; Huso D; Maitra A; Parsons MJ; Prescott JD; Leach SD
    Oncogene; 2015 May; 34(21):2801-6. PubMed ID: 25065594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system.
    Liu S; Leach SD
    Methods Cell Biol; 2011; 105():367-81. PubMed ID: 21951538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.
    Park SW; Davison JM; Rhee J; Hruban RH; Maitra A; Leach SD
    Gastroenterology; 2008 Jun; 134(7):2080-90. PubMed ID: 18549880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer.
    Schiavone M; Rampazzo E; Casari A; Battilana G; Persano L; Moro E; Liu S; Leach SD; Tiso N; Argenton F
    Dis Model Mech; 2014 Jul; 7(7):883-94. PubMed ID: 24878567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa.
    Jafari M; Laraqui A; Baba W; Benmokhtar S; Zaitouni SE; Ali AA; Bounaim A; Moujahid M; Tanz R; Mahfoud T; Sbitti Y; Annaz HE; Abi R; Tagajdid MR; Kochri SE; Lahlou IA; Hsaini HE; Belayachi L; Benjouad A; Ichou M; En-Nya A; Ennibi K
    BMC Cancer; 2022 Nov; 22(1):1142. PubMed ID: 36344948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells.
    Visani M; de Biase D; Baccarini P; Fabbri C; Polifemo AM; Zanini N; Pession A; Tallini G
    Int J Surg Pathol; 2013 Dec; 21(6):546-52. PubMed ID: 23426962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
    Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
    Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Will molecular diagnostics become established in pancreatic pathology?].
    Sipos B; Sperveslage J
    Pathologe; 2013 Nov; 34 Suppl 2():214-20. PubMed ID: 24196616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for KRAS in pancreatic tumor development and progression.
    di Magliano MP; Logsdon CD
    Gastroenterology; 2013 Jun; 144(6):1220-9. PubMed ID: 23622131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia.
    Ray KC; Moss ME; Franklin JL; Weaver CJ; Higginbotham J; Song Y; Revetta FL; Blaine SA; Bridges LR; Guess KE; Coffey RJ; Crawford HC; Washington MK; Means AL
    Oncogene; 2014 Feb; 33(7):823-31. PubMed ID: 23376846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.
    Sawai Y; Kodama Y; Shimizu T; Ota Y; Maruno T; Eso Y; Kurita A; Shiokawa M; Tsuji Y; Uza N; Matsumoto Y; Masui T; Uemoto S; Marusawa H; Chiba T
    Cancer Res; 2015 Aug; 75(16):3292-301. PubMed ID: 26113087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; CaƱamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
    Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
    Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.
    Bisht S; Ahmad F; Sawaimoon S; Bhatia S; Das BR
    Med Oncol; 2014 Sep; 31(9):124. PubMed ID: 25073438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas].
    Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.
    Ray KC; Bell KM; Yan J; Gu G; Chung CH; Washington MK; Means AL
    PLoS One; 2011 Feb; 6(2):e16786. PubMed ID: 21311774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rare transforming KRAS mutations in sporadic colorectal cancer.
    Tong JH; Lung RW; Sin FM; Law PP; Kang W; Chan AW; Ma BB; Mak TW; Ng SS; To KF
    Cancer Biol Ther; 2014 Jun; 15(6):768-76. PubMed ID: 24642870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish.
    Davison JM; Woo Park S; Rhee JM; Leach SD
    Methods Enzymol; 2008; 438():391-417. PubMed ID: 18413263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.